Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Capital Reinvestment Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.76 Million) in capital expenditures (CN¥3.59 Million). Check 002424 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Bailing Group Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Guizhou Bailing Group Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see Guizhou Bailing Group Pharmaceutical Co cash conversion from operations.
Annual Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd from 2009 to 2025. See 002424 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥748.72 Million | CN¥125.24 Million | ▼ -96.4% |
| 2024 | 4.66x | CN¥9.02 Million | CN¥42.02 Million | ▲ +462.6% |
| 2023 | 0.83x | CN¥125.77 Million | CN¥104.12 Million | ▲ +507.3% |
| 2022 | 0.14x | CN¥502.15 Million | CN¥68.45 Million | ▼ -89.6% |
| 2021 | 1.31x | CN¥324.92 Million | CN¥425.73 Million | ▲ +237.3% |
| 2020 | 0.39x | CN¥231.78 Million | CN¥90.02 Million | ▲ +48.9% |
| 2019 | 0.26x | CN¥467.41 Million | CN¥121.91 Million | ▼ -85.6% |
| 2017 | 1.81x | CN¥79.88 Million | CN¥144.68 Million | ▲ +430.4% |
| 2016 | 0.34x | CN¥466.62 Million | CN¥159.34 Million | ▲ +16.6% |
| 2015 | 0.29x | CN¥413.23 Million | CN¥121.04 Million | ▲ +20.2% |
| 2014 | 0.24x | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥125.31 Million | CN¥21.91 Million | — |